Class information for:
Level 1: CYTOMEGALOVIRUS//VALGANCICLOVIR//PREEMPTIVE THERAPY

Basic class information

Class id #P Avg. number of
references
Database coverage
of references
405 3527 29.7 82%



Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes

The table includes all classes above and classes immediately below the current class.



Cluster id Level Cluster label #P
7 4 INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY 1353914
220 3       CYTOMEGALOVIRUS//VIROLOGY//JOURNAL OF VIROLOGY 50388
429 2             CYTOMEGALOVIRUS//HUMAN CYTOMEGALOVIRUS//HUMAN HERPESVIRUS 6 16394
405 1                   CYTOMEGALOVIRUS//VALGANCICLOVIR//PREEMPTIVE THERAPY 3527

Terms with highest relevance score



rank Term termType Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with term
in class
1 CYTOMEGALOVIRUS authKW 1120321 21% 17% 744
2 VALGANCICLOVIR authKW 675397 4% 57% 136
3 PREEMPTIVE THERAPY authKW 565936 3% 65% 101
4 ANTIGENEMIA authKW 359642 2% 52% 80
5 GANCICLOVIR authKW 343910 6% 20% 196
6 CYTOMEGALOVIRUS INFECTION authKW 325977 3% 33% 115
7 CMV authKW 250029 5% 17% 168
8 PP65 ANTIGENEMIA authKW 163523 1% 82% 23
9 CMV INFECTION authKW 138492 1% 34% 47
10 TRANSPLANTATION WoSSC 121039 38% 1% 1357

Web of Science journal categories



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with term
in class
1 Transplantation 121039 38% 1% 1357
2 Immunology 22115 38% 0% 1352
3 Surgery 10092 30% 0% 1045
4 Infectious Diseases 8157 15% 0% 524
5 Virology 5963 10% 0% 363
6 Microbiology 5087 17% 0% 596
7 Hematology 3574 10% 0% 366
8 Urology & Nephrology 580 4% 0% 158
9 Medicine, General & Internal 418 7% 0% 237
10 Pathology 288 3% 0% 115

Address terms



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 UNIV MED ASSOCIATES 34623 0% 100% 4
2 HEMATOL MED ONCOL SERV 32784 0% 32% 12
3 HEPATOBILIARY PANCREAT SURG HEPAT TRANSPLANT 27697 0% 80% 4
4 SPERIMENTALI RIC 22300 0% 18% 14
5 FDN INCLIVA 19667 0% 45% 5
6 TRANSPLANT INFECT DIS 17662 0% 29% 7
7 KLIN ABT ANASTHESIE INTENS MED 17311 0% 100% 2
8 MIX UNIT 5164 17311 0% 100% 2
9 MOL VIROL PATHOL MICROBIOL 17311 0% 100% 2
10 RENAL TRANSPLANTAT NEPHROL 17311 0% 100% 2

Journals



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 TRANSPLANTATION PROCEEDINGS 43360 13% 1% 449
2 TRANSPLANT INFECTIOUS DISEASE 43333 2% 7% 76
3 TRANSPLANTATION 35637 8% 2% 276
4 BONE MARROW TRANSPLANTATION 19682 4% 2% 142
5 JOURNAL OF CLINICAL VIROLOGY 14834 2% 2% 76
6 JOURNAL OF CLINICAL MICROBIOLOGY 13522 6% 1% 205
7 AMERICAN JOURNAL OF TRANSPLANTATION 12439 2% 2% 83
8 CLINICAL AND DIAGNOSTIC VIROLOGY 11881 0% 8% 17
9 JOURNAL OF MEDICAL VIROLOGY 11011 3% 1% 99
10 CLINICAL TRANSPLANTATION 9157 2% 2% 63

Author Key Words



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
LCSH search Wikipedia search
1 CYTOMEGALOVIRUS 1120321 21% 17% 744 Search CYTOMEGALOVIRUS Search CYTOMEGALOVIRUS
2 VALGANCICLOVIR 675397 4% 57% 136 Search VALGANCICLOVIR Search VALGANCICLOVIR
3 PREEMPTIVE THERAPY 565936 3% 65% 101 Search PREEMPTIVE+THERAPY Search PREEMPTIVE+THERAPY
4 ANTIGENEMIA 359642 2% 52% 80 Search ANTIGENEMIA Search ANTIGENEMIA
5 GANCICLOVIR 343910 6% 20% 196 Search GANCICLOVIR Search GANCICLOVIR
6 CYTOMEGALOVIRUS INFECTION 325977 3% 33% 115 Search CYTOMEGALOVIRUS+INFECTION Search CYTOMEGALOVIRUS+INFECTION
7 CMV 250029 5% 17% 168 Search CMV Search CMV
8 PP65 ANTIGENEMIA 163523 1% 82% 23 Search PP65+ANTIGENEMIA Search PP65+ANTIGENEMIA
9 CMV INFECTION 138492 1% 34% 47 Search CMV+INFECTION Search CMV+INFECTION
10 CYTOMEGALOVIRUS DISEASE 119389 1% 53% 26 Search CYTOMEGALOVIRUS+DISEASE Search CYTOMEGALOVIRUS+DISEASE

Core articles

The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.



Rank Reference # ref. in
cl.
Shr. of ref. in
cl.
Citations
1 KOTTON, CN , KUMAR, D , CALIENDO, AM , ASBERG, A , CHOU, SW , DANZIGER-ISAKOV, L , HUMAR, A , (2013) UPDATED INTERNATIONAL CONSENSUS GUIDELINES ON THE MANAGEMENT OF CYTOMEGALOVIRUS IN SOLID-ORGAN TRANSPLANTATION.TRANSPLANTATION. VOL. 96. ISSUE 4. P. 333-360 158 66% 174
2 SIA, IG , PATEL, R , (2000) NEW STRATEGIES FOR PREVENTION AND THERAPY OF CYTOMEGALOVIRUS INFECTION AND DISEASE IN SOLID-ORGAN TRANSPLANT RECIPIENTS.CLINICAL MICROBIOLOGY REVIEWS. VOL. 13. ISSUE 1. P. 83 -+ 297 66% 142
3 TORRE-CISNEROS, J , AGUADO, JM , GASTON, JJ , ALMENAR, L , ALONSO, A , CANTISAN, S , CARRATALA, J , CERVERA, C , CORDERO, E , FARINAS, MC , ET AL (2016) MANAGEMENT OF CYTOMEGALOVIRUS INFECTION IN SOLID ORGAN TRANSPLANT RECIPIENTS: SET/GESITRA-SEIMC/REIPI RECOMMENDATIONS.TRANSPLANTATION REVIEWS. VOL. 30. ISSUE 3. P. 119 -143 191 67% 1
4 RAZONABLE, RR , HAYDEN, RT , (2013) CLINICAL UTILITY OF VIRAL LOAD IN MANAGEMENT OF CYTOMEGALOVIRUS INFECTION AFTER SOLID ORGAN TRANSPLANTATION.CLINICAL MICROBIOLOGY REVIEWS. VOL. 26. ISSUE 4. P. 703-727 157 78% 28
5 HODSON, EM , LADHANI, M , WEBSTER, AC , STRIPPOLI, GFM , CRAIG, JC , (2013) ANTIVIRAL MEDICATIONS FOR PREVENTING CYTOMEGALOVIRUS DISEASE IN SOLID ORGAN TRANSPLANT RECIPIENTS.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 2. P. - 120 85% 29
6 DE LA TORRE-CISNEROS, J , FARINAS, MC , CASTON, JJ , AGUADO, JM , CANTISAN, S , CARRATALA, J , CERVERA, C , CISNEROS, JM , CORDERO, E , CRESPO-LEIRO, MG , ET AL (2011) GESITRA-SEIMC/REIPI RECOMMENDATIONS FOR THE MANAGEMENT OF CYTOMEGALOVIRUS INFECTION IN SOLID-ORGAN TRANSPLANT PATIENTS.ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. VOL. 29. ISSUE 10. P. 735 -758 153 67% 28
7 BOECKH, M , BOIVIN, G , (1998) QUANTITATION OF CYTOMEGALOVIRUS: METHODOLOGIC ASPECTS AND CLINICAL APPLICATIONS.CLINICAL MICROBIOLOGY REVIEWS. VOL. 11. ISSUE 3. P. 533-+ 135 81% 253
8 OWERS, DS , WEBSTER, AC , STRIPPOLI, GFM , KABLE, K , HODSON, EM , (2013) PRE-EMPTIVE TREATMENT FOR CYTOMEGALOVIRUS VIRAEMIA TO PREVENT CYTOMEGALOVIRUS DISEASE IN SOLID ORGAN TRANSPLANT RECIPIENTS.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 2. P. - 106 89% 3
9 KOTTON, CN , (2013) CMV: PREVENTION, DIAGNOSIS AND THERAPY.AMERICAN JOURNAL OF TRANSPLANTATION. VOL. 13. ISSUE . P. 24-40 93 68% 56
10 RAZONABLE, RR , HUMAR, A , (2013) CYTOMEGALOVIRUS IN SOLID ORGAN TRANSPLANTATION.AMERICAN JOURNAL OF TRANSPLANTATION. VOL. 13. ISSUE . P. 93-106 67 77% 99

Classes with closest relation at Level 1



Rank Class id link
1 15771 UL97//GANCICLOVIR RESISTANCE//MARIBAVIR
2 18635 CMV PREVENTION//TRANSFUSION ASSOCIATED INFECTION//ACUTE EBV INFECTION VZV SPECIFIC IGA
3 13148 CYTOMEGALOVIRUS//CYTOMEGALOVIRUS COLITIS//IMMUNOCOMPETENT
4 5022 GUINEA PIG CYTOMEGALOVIRUS//CYTOMEGALOVIRUS//MURINE CYTOMEGALOVIRUS
5 19136 CYTOMEGALOVIRUS//INFECTION BARRIER//RAT HEART ENDOTHELIAL CELL LINES
6 35362 HYPOGAMMAGLOBULINEMIA//ANTIBODY REPLACEMENT THERAPY//ASTA Z 7557
7 786 HUMAN CYTOMEGALOVIRUS//HCMV//VIROLOGY
8 13768 SURG NURSING TRANSPLANTAT//ACUTE GRAFT PYELONEPHRITIS//TRANSPLANT MED NEPHROL
9 5259 CYTOMEGALOVIRUS RETINITIS//CMV RETINITIS//RETINITIS
10 4155 CONGENITAL INFECTION//CYTOMEGALOVIRUS//CONGENITAL CYTOMEGALOVIRUS INFECTION

Go to start page